SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-20-002336
Filing Date
2020-07-22
Accepted
2020-07-22 08:51:59
Documents
6
Effectiveness Date
2020-07-22

Document Format Files

Seq Description Document Type Size
1 FORM S-8 cns_s8.htm S-8 58931
2 OPINION AND CONSENT OF COUNSEL cns_ex0501.htm EX-5.1 6674
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cns_ex2301.htm EX-23.1 2795
4 2017 STOCK PLAN cns_ex9901.htm EX-99.1 177478
5 2020 STOCK PLAN cns_ex9902.htm EX-99.2 171633
6 GRAPHIC image_012.jpg GRAPHIC 7440
  Complete submission text file 0001683168-20-002336.txt   428912
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239998 | Film No.: 201040368
SIC: 2834 Pharmaceutical Preparations